{
  "buckets": {
    "module": {
      "999000011000000103": 27,
      "900000000000207008": 21
    },
    "semanticTags": {
      "observable entity": 17
    },
    "language": {
      "en": 48
    },
    "membership": {
      "1322291000000109": 17,
      "900000000000497000": 8,
      "733073007": 17,
      "966261000000100": 1
    }
  },
  "languageNames": {
    "en": "english"
  },
  "bucketConcepts": {
    "1322291000000109": {
      "conceptId": "1322291000000109",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000041000000102",
      "fsn": {
        "term": "National Health Service Care Record Element association reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "NHS Care Record Element association reference set",
        "lang": "en"
      },
      "id": "1322291000000109"
    },
    "900000000000497000": {
      "conceptId": "900000000000497000",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "CTV3 to SNOMED CT simple map reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "CTV3 to SNOMED CT simple map",
        "lang": "en"
      },
      "id": "900000000000497000"
    },
    "733073007": {
      "conceptId": "733073007",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "OWL axiom reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "OWL axiom reference set",
        "lang": "en"
      },
      "id": "733073007"
    },
    "999000011000000103": {
      "conceptId": "999000011000000103",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000041000000102",
      "fsn": {
        "term": "SNOMED CT United Kingdom clinical extension module (core metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "SNOMED CT United Kingdom clinical extension module",
        "lang": "en"
      },
      "id": "999000011000000103"
    },
    "966261000000100": {
      "conceptId": "966261000000100",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "999000021000000109",
      "fsn": {
        "term": "Speech and language therapy assessment observables simple reference set (foundation metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "Speech and language therapy assessment observables simple reference set",
        "lang": "en"
      },
      "id": "966261000000100"
    },
    "900000000000207008": {
      "conceptId": "900000000000207008",
      "active": true,
      "definitionStatus": "PRIMITIVE",
      "moduleId": "900000000000012004",
      "fsn": {
        "term": "SNOMED CT core module (core metadata concept)",
        "lang": "en"
      },
      "pt": {
        "term": "SNOMED CT core",
        "lang": "en"
      },
      "id": "900000000000207008"
    }
  },
  "totalElements": 48,
  "totalPages": 1,
  "last": true,
  "numberOfElements": 48,
  "first": true,
  "size": 50,
  "number": 0,
  "items": [
    {
      "term": "Minimal erythema dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251354007",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal erythema dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal erythema dose",
          "lang": "en"
        },
        "id": "251354007"
      }
    },
    {
      "term": "Minimal phototest dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251353001",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal phototest dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal phototest dose",
          "lang": "en"
        },
        "id": "251353001"
      }
    },
    {
      "term": "Minimal indicated dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251355008",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal indicated dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal indicated dose",
          "lang": "en"
        },
        "id": "251355008"
      }
    },
    {
      "term": "Minimal effective dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251356009",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal effective dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal effective dose",
          "lang": "en"
        },
        "id": "251356009"
      }
    },
    {
      "term": "Minimal phototoxic dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251357000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal phototoxic dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal phototoxic dose",
          "lang": "en"
        },
        "id": "251357000"
      }
    },
    {
      "term": "Minimal urticarial dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "373907006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal urticarial dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal urticarial dose",
          "lang": "en"
        },
        "id": "373907006"
      }
    },
    {
      "term": "Minimal identifiable odor",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "80564000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal identifiable odor, function (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal identifiable odor",
          "lang": "en"
        },
        "id": "80564000"
      }
    },
    {
      "term": "Minimal identifiable odour",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "80564000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal identifiable odor, function (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal identifiable odor",
          "lang": "en"
        },
        "id": "80564000"
      }
    },
    {
      "term": "MED - Minimal erythema dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251354007",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal erythema dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal erythema dose",
          "lang": "en"
        },
        "id": "251354007"
      }
    },
    {
      "term": "MPD - Minimal phototoxic dose",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251357000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal phototoxic dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal phototoxic dose",
          "lang": "en"
        },
        "id": "251357000"
      }
    },
    {
      "term": "Minimal identifiable odor, function",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "80564000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal identifiable odor, function (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal identifiable odor",
          "lang": "en"
        },
        "id": "80564000"
      }
    },
    {
      "term": "Minimal erythema dose (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251354007",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal erythema dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal erythema dose",
          "lang": "en"
        },
        "id": "251354007"
      }
    },
    {
      "term": "Minimal phototest dose (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251353001",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal phototest dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal phototest dose",
          "lang": "en"
        },
        "id": "251353001"
      }
    },
    {
      "term": "Minimal indicated dose (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251355008",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal indicated dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal indicated dose",
          "lang": "en"
        },
        "id": "251355008"
      }
    },
    {
      "term": "Minimal effective dose (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251356009",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal effective dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal effective dose",
          "lang": "en"
        },
        "id": "251356009"
      }
    },
    {
      "term": "Minimal phototoxic dose (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "251357000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal phototoxic dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal phototoxic dose",
          "lang": "en"
        },
        "id": "251357000"
      }
    },
    {
      "term": "Minimal urticarial dose (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "373907006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal urticarial dose (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal urticarial dose",
          "lang": "en"
        },
        "id": "373907006"
      }
    },
    {
      "term": "Test of Minimal Articulation Competence score",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "718409006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Test of Minimal Articulation Competence score (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Test of Minimal Articulation Competence score",
          "lang": "en"
        },
        "id": "718409006"
      }
    },
    {
      "term": "T-MAC (Test of Minimal Articulation Competence) score",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "718409006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Test of Minimal Articulation Competence score (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Test of Minimal Articulation Competence score",
          "lang": "en"
        },
        "id": "718409006"
      }
    },
    {
      "term": "Minimal identifiable odor, function (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "80564000",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Minimal identifiable odor, function (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Minimal identifiable odor",
          "lang": "en"
        },
        "id": "80564000"
      }
    },
    {
      "term": "Test of Minimal Articulation Competence score (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "900000000000207008",
      "concept": {
        "conceptId": "718409006",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "900000000000207008",
        "fsn": {
          "term": "Test of Minimal Articulation Competence score (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Test of Minimal Articulation Competence score",
          "lang": "en"
        },
        "id": "718409006"
      }
    },
    {
      "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464671000000104",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464671000000104"
      }
    },
    {
      "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464671000000104",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464671000000104"
      }
    },
    {
      "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464781000000105",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464781000000105"
      }
    },
    {
      "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464671000000104",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464671000000104"
      }
    },
    {
      "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464741000000102",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464741000000102"
      }
    },
    {
      "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464781000000105",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464781000000105"
      }
    },
    {
      "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464741000000102",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464741000000102"
      }
    },
    {
      "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464761000000101",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464761000000101"
      }
    },
    {
      "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464761000000101",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464761000000101"
      }
    },
    {
      "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464781000000105",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time in target glucose range to total glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464781000000105"
      }
    },
    {
      "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464741000000102",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Standard deviation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464741000000102"
      }
    },
    {
      "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464821000000102",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464821000000102"
      }
    },
    {
      "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464831000000100",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464831000000100"
      }
    },
    {
      "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464791000000107",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464791000000107"
      }
    },
    {
      "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464801000000106",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464801000000106"
      }
    },
    {
      "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464761000000101",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Coefficient of variation of mean substance concentration of glucose in capillary blood using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464761000000101"
      }
    },
    {
      "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464941000000100",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464941000000100"
      }
    },
    {
      "term": "Percentage of time below level 2 hypoglycaemic threshold to total CGM (continuous glucose monitoring) time using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464821000000102",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464821000000102"
      }
    },
    {
      "term": "Percentage of time below level 1 hypoglycaemic threshold to total CGM (continuous glucose monitoring) time using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464831000000100",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464831000000100"
      }
    },
    {
      "term": "Percentage of time above level 2 hyperglycaemic threshold to total CGM (continuous glucose monitoring) time using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464791000000107",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464791000000107"
      }
    },
    {
      "term": "Percentage of time above level 1 hyperglycaemic threshold to total CGM (continuous glucose monitoring) time using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464801000000106",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464801000000106"
      }
    },
    {
      "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive CGM (continuous glucose monitoring) device",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464941000000100",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464941000000100"
      }
    },
    {
      "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464821000000102",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time below level 2 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464821000000102"
      }
    },
    {
      "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464831000000100",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time below level 1 hypoglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464831000000100"
      }
    },
    {
      "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464791000000107",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time above level 2 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464791000000107"
      }
    },
    {
      "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464801000000106",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of time above level 1 hyperglycaemic threshold to total continuous glucose monitoring time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464801000000106"
      }
    },
    {
      "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device (observable entity)",
      "active": true,
      "languageCode": "en",
      "module": "999000011000000103",
      "concept": {
        "conceptId": "1464941000000100",
        "active": true,
        "definitionStatus": "PRIMITIVE",
        "moduleId": "999000011000000103",
        "fsn": {
          "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device (observable entity)",
          "lang": "en"
        },
        "pt": {
          "term": "Percentage of successful data capture time to total expected continuous glucose monitoring sensor wear time using minimally-invasive continuous glucose monitoring device",
          "lang": "en"
        },
        "id": "1464941000000100"
      }
    }
  ]
}